Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 73.52%19.49M | 31.56%16.84M | -30.49%8.75M | -2.25%45.94M | -9.91%9.33M | -15.33%11.23M | 2.73%12.8M | 15.23%12.58M | -20.77%47M | -12.74%10.36M |
| Cost of revenue | 82.01%15.4M | 34.97%13.27M | -35.71%6.16M | -2.57%35.69M | -0.17%7.81M | -20.13%8.46M | -0.17%9.83M | 14.63%9.58M | -17.82%36.63M | -17.03%7.83M |
| Gross profit | 47.60%4.09M | 20.26%3.57M | -13.81%2.58M | -1.13%10.26M | -40.03%1.52M | 3.74%2.77M | 13.66%2.97M | 17.21%3M | -29.68%10.37M | 3.84%2.53M |
| Operating expense | -3.44%2.66M | 7.22%3.44M | 1.47%3.25M | -15.44%12.14M | -12.39%3.1M | -20.27%2.76M | -15.67%3.21M | -16.55%3.21M | 35.37%14.36M | -21.89%3.54M |
| Selling and administrative expenses | -16.43%2.63M | 2.55%3.42M | -6.44%3.11M | -12.40%12.81M | -13.42%3.01M | -10.99%3.14M | -12.56%3.34M | -12.62%3.32M | -21.06%14.63M | -27.03%3.48M |
| -Selling and marketing expense | -7.75%929K | 38.89%1.13M | -26.01%711K | -10.53%3.56M | -3.69%784K | 1.82%1.01M | -24.37%810K | -13.27%961K | -31.37%3.98M | -45.56%814K |
| -General and administrative expense | -20.52%1.7M | -9.11%2.3M | 1.52%2.4M | -13.10%9.25M | -16.39%2.23M | -15.98%2.13M | -7.95%2.53M | -12.35%2.36M | -16.36%10.65M | -18.56%2.67M |
| Other operating expenses | -16.90%59K | 124.76%236K | 418.52%280K | -35.53%278.5K | -25.44%255K | -41.80%71K | -36.75%105K | -70.33%54K | -28.15%431.96K | 1,427.49%342K |
| Total other operating income | -95.37%21K | -7.02%212K | -20.35%137K | 35.47%952.86K | -41.22%164K | 136.46%454K | 33.33%228K | 19.44%172K | -91.75%703.38K | 34.78%279K |
| Operating profit | 10,876.92%1.43M | 153.53%129K | -220.57%-670K | 52.74%-1.88M | -56.93%-1.59M | 101.65%13K | 79.83%-241K | 83.74%-209K | -195.95%-3.98M | 51.83%-1.01M |
| Net non-operating interest income (expenses) | 68.75%-10K | 61.54%-20K | 81.82%-18K | 52.73%-192.9K | 89.01%-10K | 69.52%-32K | 50.94%-52K | 6.60%-99K | 28.90%-408.06K | 20.12%-91K |
| Non-operating interest income | ---- | ---- | ---- | 16.29%14.6K | ---- | ---- | ---- | ---- | 22.93%12.56K | ---- |
| Non-operating interest expense | -68.75%10K | -61.54%20K | -81.82%18K | -50.67%207.5K | -89.01%10K | -69.52%32K | -50.94%52K | -6.60%99K | -27.99%420.61K | -26.69%91K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 11.14%1.51K | 38.93%1.36K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 52.18%-142.68K | -386.49%-298.34K | ||||||||
| Less:Write off | ---- | ---- | ---- | -52.18%142.68K | ---- | ---- | ---- | ---- | 386.49%298.34K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 7,557.89%1.42M | 137.20%109K | -123.38%-688K | 52.72%-2.22M | -44.87%-1.6M | 97.87%-19K | 77.48%-293K | 77.86%-308K | -233.32%-4.69M | 51.52%-1.1M |
| Income tax | -4.55%21K | 30.77%34K | 0.00%15K | -83.95%45.85K | -109.94%-17K | -71.79%22K | 4.00%26K | 25.00%15K | -27.45%285.72K | 141.49%171K |
| Net income | 3,504.88%1.4M | 123.51%75K | -117.65%-703K | 54.52%-2.26M | -24.06%-1.58M | 95.78%-41K | 75.94%-319K | 76.98%-323K | -259.30%-4.97M | 31.57%-1.27M |
| Net income continuous operations | 3,504.88%1.4M | 123.51%75K | -117.65%-703K | 54.52%-2.26M | -24.06%-1.58M | 95.78%-41K | 75.94%-319K | 76.98%-323K | -259.30%-4.97M | 31.57%-1.27M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 3,504.88%1.4M | 123.51%75K | -117.65%-703K | 54.52%-2.26M | -24.06%-1.58M | 95.78%-41K | 75.94%-319K | 76.98%-323K | -259.30%-4.97M | 31.57%-1.27M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3,504.88%1.4M | 123.51%75K | -117.65%-703K | 54.52%-2.26M | -24.06%-1.58M | 95.78%-41K | 75.94%-319K | 76.98%-323K | -259.30%-4.97M | 31.57%-1.27M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 3,050.00%0.0059 | 121.43%0.0003 | -114.29%-0.003 | 54.72%-0.0096 | -24.07%-0.0067 | 95.12%-0.0002 | 75.00%-0.0014 | 76.67%-0.0014 | -259.40%-0.0212 | 31.65%-0.0054 |
| Diluted earnings per share | 3,050.00%0.0059 | 121.43%0.0003 | -114.29%-0.003 | 54.72%-0.0096 | -24.07%-0.0067 | 95.12%-0.0002 | 75.00%-0.0014 | 76.67%-0.0014 | -259.40%-0.0212 | 31.65%-0.0054 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.